GlassScriptPhysician profile
Syed Ahmad
NPI 1508898289
$3,031.91
in general payments reported to CMS, 2019-2025
13 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $167 · 2021: $125 · 2022: $671 · 2023: $785 · 2024: $423 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,066.64 | 2022-2025 | |
| Novo Nordisk INC | $563.13 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $374.17 | 2021-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $271.52 | 2019-2023 | Fasenra |
| Merck Sharp & Dohme LLC | $257.71 | 2019-2023 | Verquvo |
| Lilly USA, LLC | $213.70 | 2019-2025 | Zepbound, Mounjaro |
| Vifor Pharma, INC. | $98.31 | 2023 | Veltassa |
| Pfizer INC. | $56.10 | 2023-2024 | |
| Exact Sciences Corporation | $42.76 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $36.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.44 | 2019 | |
| Philips North America LLC | $15.89 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.